Evidence map›Paper›PMID 41460274›Full record

ArticleJournal of computer-aided molecular design2025

Unveiling structural dynamics and allosteric vulnerabilities in Klebsiella pneumoniae KPHS_11890: an integrated DRKG-MD study.

Zhenghua Jiang, Mengqi Huang, Yemei Bu, Siqi Wu, Sijun Meng, Zhaochun Wu, Hesong Qiu, Lingling Wang, Nijun Wei, Wen Zhang and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Zhenghua Jiang *Nanping First Hospital Affiliated to Fujian Medical University, No. 317, Zhongshan Road, Yanping District, Nanping, 353099, Fujian Province, P. R. China. 798563491@qq.com.
Mengqi Huang *JIYING TECHNOLOGY CO, LIMITED. Rm 27, Space 109B-113, ITC, 1/F, 5W, Science 7 Technology Ave, Shatin, N.T., , Shatin, P. R. China. mrhuang_mq@163.com.ORCID http://orcid.org/0009-0009-6552-4319
Yemei Bu *Nanping First Hospital Affiliated to Fujian Medical University, No. 317, Zhongshan Road, Yanping District, Nanping, 353099, Fujian Province, P. R. China.
Siqi Wu *School of Medicine, Xiamen University, No. 4221-122, Xiang'an South Road, Xiamen, 361102, Fujian Province, P. R. China.
Sijun Meng *JIYING TECHNOLOGY CO, LIMITED. Rm 27, Space 109B-113, ITC, 1/F, 5W, Science 7 Technology Ave, Shatin, N.T., , Shatin, P. R. China.
Zhaochun WuNanping First Hospital Affiliated to Fujian Medical University, No. 317, Zhongshan Road, Yanping District, Nanping, 353099, Fujian Province, P. R. China.
Hesong QiuJIYING TECHNOLOGY CO, LIMITED. Rm 27, Space 109B-113, ITC, 1/F, 5W, Science 7 Technology Ave, Shatin, N.T., , Shatin, P. R. China.
Lingling WangDepartment of Applied Biology and Chemical Technology, PolyU Marshall Research Centre for Medical Microbial Biotechnology, The Hong Kong Polytechnic University, Kowloon, 999077, Hong Kong SAR, P. R. China.
Nijun WeiJIYING TECHNOLOGY CO, LIMITED. Rm 27, Space 109B-113, ITC, 1/F, 5W, Science 7 Technology Ave, Shatin, N.T., , Shatin, P. R. China.
Wen ZhangJIYING TECHNOLOGY CO, LIMITED. Rm 27, Space 109B-113, ITC, 1/F, 5W, Science 7 Technology Ave, Shatin, N.T., , Shatin, P. R. China.
Xunxing WangJIYING TECHNOLOGY CO, LIMITED. Rm 27, Space 109B-113, ITC, 1/F, 5W, Science 7 Technology Ave, Shatin, N.T., , Shatin, P. R. China.
Jiali ZhouSchool of Medicine, Xiamen University, No. 4221-122, Xiang'an South Road, Xiamen, 361102, Fujian Province, P. R. China.
Dongli LuNanping First Hospital Affiliated to Fujian Medical University, No. 317, Zhongshan Road, Yanping District, Nanping, 353099, Fujian Province, P. R. China.
Zhichao HongNanping First Hospital Affiliated to Fujian Medical University, No. 317, Zhongshan Road, Yanping District, Nanping, 353099, Fujian Province, P. R. China.
Gaohong ZhaoJIYING TECHNOLOGY CO, LIMITED. Rm 27, Space 109B-113, ITC, 1/F, 5W, Science 7 Technology Ave, Shatin, N.T., , Shatin, P. R. China.
Cong MaDepartment of Applied Biology and Chemical Technology, PolyU Marshall Research Centre for Medical Microbial Biotechnology, The Hong Kong Polytechnic University, Kowloon, 999077, Hong Kong SAR, P. R. China. cong.ma@polyu.edu.hk.

Funding

the Innovation and Technology Commission of Hong Kong SAR government of China ITF PRP/062/22FX
6 · The paper itself

Abstract

Klebsiella pneumoniae (K. pneumoniae), a multidrug-resistant Gram-negative bacillus, represents a significant global health threat due to its role in hospital-acquired infections and the emergence of carbapenem-resistant hypervirulent strains. This study integrates the Drug Repurposing Knowledge Graph (DRKG) with molecular dynamics (MD) simulations to identify and validate stable structural segments of the KPHS_11890 gene, which encodes a membrane fusion protein of the AcrAB-TolC efflux pump that is critical for antibiotic resistance in K. pneumoniae. Using the PyKEEN framework, a knowledge graph embedding model was trained on a comprehensive dataset combining DrugBank, K. pneumoniae strain sequences, and NCBI databases, identifying KPHS_11890 as a top-ranked candidate (Hits@10 = 0.1602). The structural reliability of the target was first confirmed via rigorous quality assessment (Ramachandran plot, ERRAT, and ProSA), followed by triplicate 100-ns molecular dynamics simulations using GROMACS 2025. The integrated analysis of essential dynamics and free energy landscapes (FEL) revealed a thermodynamically stable core domain (residues 18-342) and a critical functional hinge region near residue 115. The structural rigidity of the core suggests minimized entropic penalties for inhibitor binding, while the identified hinge motion presents a specific mechanical vulnerability for allosteric locking. This integrated DRKG-MD approach not only efficiently pinpoints high-potential targets but also elucidates their biophysical mechanisms, providing a robust structural basis for designing novel inhibitors to overcome efflux pump-mediated resistance.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsKlebsiella pneumoniaeMolecular Dynamics SimulationAllosteric RegulationDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsBacterial ProteinsAntibiotic resistanceDrug target identificationKlebsiella pneumoniaeKnowledge graphMolecular dynamics simulation

Identifiers

PMID41460274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.